FDA Approved: SEVELAMER CARBONATE — Original Application (Sanofi-Aventis U.S. LLC)

View source ↗

Summary

FDA approved SEVELAMER CARBONATE (Sanofi-Aventis U.S. LLC) for control of serum phosphate in adults with chronic kidney disease on dialysis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Kidney Disease
• Hyperphosphatemia

Drugs mentioned

• SEVELAMER CARBONATE (sevelamer carbonate)

Snippet

ORIG AP for SEVELAMER CARBONATE (SEVELAMER CARBONATE)